HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome.

Abstract
Long-term survival after lung transplantation remains limited by the development of bronchiolitis obliterans syndrome (BOS). Allograft colonization with Pseudomonas aeruginosa is common particularly in recipients with BOS, but a possible etiological relationship remains unexplored. In 155 consecutive lung transplants, the development of allograft colonization with Pseudomonas was strongly associated with the development of BOS within 2 years of transplant (23.4% vs. 7.7% in those colonized and not colonized, respectively, P=0.006). Freedom from BOS was significantly shorter in those patients without any pretransplant bacterial reservoir developing de novo allograft pseudomonal colonization as compared with those remaining free of colonization (Kaplan-Meier log-rank P=0.014). The isolation of Pseudomonas preceded the diagnosis of BOS in 14 of 18 (78%) and by a median of 204 days (95% confidence interval 115-492) in patients developing both these complications. We conclude that de novo colonization of the lung allograft by Pseudomonas is strongly associated with the subsequent development of BOS.
AuthorsPhil Botha, Lynda Archer, Rachel L Anderson, Jim Lordan, John H Dark, Paul A Corris, Kate Gould, Andrew J Fisher
JournalTransplantation (Transplantation) Vol. 85 Issue 5 Pg. 771-4 (Mar 15 2008) ISSN: 0041-1337 [Print] United States
PMID18337673 (Publication Type: Journal Article)
Topics
  • Adult
  • Bronchiolitis Obliterans (epidemiology, microbiology)
  • Female
  • Humans
  • Lung Transplantation (adverse effects)
  • Male
  • Middle Aged
  • Pseudomonas Infections (epidemiology)
  • Pseudomonas aeruginosa (isolation & purification)
  • Pulmonary Disease, Chronic Obstructive (epidemiology)
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: